Natco Pharma net profit slips 35pc to Rs 104 crore in Q3

New Delhi: Drug firm Natco Pharma on Wednesday reported a 34.46 per cent drop in consolidated net profit to Rs 104.4 crore for the quarter ended December 2019.

The company had posted a net profit of Rs 159.3 crore for the corresponding period of the previous fiscal, Natco Pharma said in a filing to BSE.

Read also: Patent Infringement: Case against Natco Pharma in US court over generic version of cancer drug Lonsurf

Consolidated total income stood at Rs 513 crore for the quarter under consideration. It was Rs 580 crore for the same period a year ago.

"The company continues to face margin pressures in its Hepatitis C portfolio," the filing said.

The company's board has recommended a third interim dividend of Rs 3.50 per equity share of Rs 2 each.

Read also: Natco Pharma Vizag facility begins production